Latest news for health care topics. Include medical news , health insurance , therapy and vaccine news

Wednesday, November 2, 2016

Explainer: the how, what and why of the latest HIV vaccine trial : mgafrica





as mentioned in mgafrica

Explainer: the how, what and why of the latest HIV vaccine trial

Explainer: the how, what and why of the latest HIV vaccine trial
Explainer: the how, what and why of the latest HIV vaccine trial
As the global quest for an HIV vaccine continues, Linda-Gail Bekker explains the significance of the latest large-scale trial underway in South Africa.What's the significance of the trial for the global fight against HIV?The world needs an HIV vaccine.


let alone washingtonpost

In a first, U.S. trial to test Cuban lung-cancer vaccine

In a first, U.S. trial to test Cuban lung-cancer vaccine
In a first, U.S. trial to test Cuban lung-cancer vaccine
The Food and Drug Administration has approved the first clinical trial to test a Cuban drug in the United States — a lung-cancer vaccine developed in Havana.The decision on the early-stage trial was announced Wednesday by New York Gov.Andrew Cuomo (D) and officials at the Roswell Park Cancer Institute, based in Buffalo.


by the same token on ibtimes

HIV vaccine: Large-scale clinical trial to start in South Africa to test vaccine regimen

HIV vaccine: Large-scale clinical trial to start in South Africa to test vaccine regimen
HIV vaccine: Large-scale clinical trial to start in South Africa to test vaccine regimen
A large clinical trial to test the safety and efficacy of an HIV vaccine is about to begin in South Africa.The study, known as HVTN 702, will last until 2020 and will assess whether the vaccine regimen can protect a group of healthy adults at risk of getting infected.The experimental vaccine regimen that will be tested is based on one that showed promising results in a landmark 2009 study – the Military HIV Research Program-led RV144 clinical trial in Thailand.


No comments:

Post a Comment